Skip to main content

Instinct Bio Technical Company Holdings Inc.

corporate_fare Company Profile

Instinct Bio Technical Company Holdings Inc.

BIOT·NASDAQ·Industrial Applications And Services·CIK 0000924223

Instinct Bio Technical Company Holdings Inc. operates as a stem cell technology and regenerative medicine company. It also imports, sells, manages, and delivers stem cell cosmetics. The company provides stem cell beauty essence products. Instinct Bio Technical Company Holdings Inc. was incorporated in 2015 and is based in Shinagawa, Japan.

Instinct Bio Technical Company Holdings Inc. (NASDAQ:BIOT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 6 items for BIOT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-16, rated 7/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for BIOT spans 6-K, 20-F.

Recent high-impact activity:

  • Instinct Bio Swings to Profit, Revenue Up 9.8% in Yen on First Post-Listing Results
  • Instinct Bio Hit With Three Nasdaq Delisting Notices
  • BIOT to Launch Subscription Beauty Clinics in Indonesia, Targeting $500M Market
  • Instinct Bio Closes SPAC Merger, Reveals $1.5M Negative Equity and $150M Equity Facility
  • Instinct Bio Locks In $150M Equity Funding, 12x Its Market Cap

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 26,707 shares in BIOT as of the October 30, 2026 settlement, a 75.3% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 19, 2026, 17.1% of BIOT volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)26,707 shares as of October 30, 2026
Change vs prior period▼ 75.3%
Days to cover1.00 at avg daily volume of 497,746
Daily short volume (FINRA facilities)17.1% of 105,005 shares on November 19, 2026
5-day average short volume20.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for BIOT, detected from its recent SEC filings · based on capital-structure filings through 2026-07-28.

$150M Equity Facility Proposed · Massive Dilution Overhang

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

BIOT files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with B →
$0.1675 +3.40% today
52-week range · as of 2026-09-15 $0.1675 – $50
Market cap
$4.66M
Volume
202.6K (0.6× avg)
3-mo avg 336.1K
Live data · 2026-11-20 12:53 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed BIOT - Latest Insights

BIOT
Oct 16, 2026, 8:30 AM EDT
Source: EQS
Importance Score:
7
Price at Filing: $0.280
Real-time Price: $0.1675 info
Change: -$0.1125 (-40%) info
Market Cap: $4.665M info
BIOT
Sep 15, 2026, 8:44 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.3601
Real-time Price: $0.1675 info
Change: -$0.1926 (-53%) info
Market Cap: $4.665M info
BIOT
Jul 29, 2026, 10:28 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.5608
Real-time Price: $0.1675 info
Change: -$0.3933 (-70%) info
Market Cap: $4.665M info
BIOT
Jul 28, 2026, 6:08 PM EDT
Filing Type: 20-F
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $0.1675 info
Change: -$0.8425 (-83%) info
Market Cap: $4.665M info
BIOT
Jul 28, 2026, 11:40 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.78
Real-time Price: $0.1675 info
Change: -$1.61 (-91%) info
Market Cap: $4.665M info
BIOT
Jul 28, 2026, 9:24 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.95
Real-time Price: $0.1675 info
Change: -$1.78 (-91%) info
Market Cap: $4.665M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets